|
Modeling Neoplastic Progression in Barrett's Esophagus
|
7R01CA140657-07
|
$384,742
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-02
|
$589,926
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Feasibility of Molecular Cytology for the Management of Barrett's Esophagus
|
1R21CA187753-01A1
|
$214,371
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-05
|
$1,446,550
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-01S1
|
$171,796
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-02
|
$1,360,245
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-05
|
$2,184,997
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Development of a Minimally Invasive Surgical Device for the Treatment of Esophage
|
1R43CA195948-01A1
|
$278,236
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
TissueCypher Testing for Risk Assessment in Barretts Esophagus
|
1R44CA192416-01A1
|
$624,917
|
CRITCHLEY-THORNE, REBECCA
|
CERNOSTICS, INC.
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach(2 of 2)
|
5U54CA132378-08
|
$1,205,995
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts
|
1R03CA186218-01A1
|
$81,186
|
ABRAMS, JULIAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Stem Cells And The Origins of Barrett's Esophagus
|
3U54CA163004-05S1
|
$174,160
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Stem Cells And The Origins of Barrett's Esophagus
|
5U54CA163004-05
|
$965,140
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
|
1R01CA187119-01A1
|
$383,831
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-02
|
$1,171,980
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-08
|
$2,185,000
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-02
|
$319,472
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
2P30CA014236-41
|
$5,661,203
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-41S1
|
$56,234
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Nanoplasmonics-based molecular analysis tool for molecular biomarkers of cancer
|
1R21CA196426-01
|
$202,431
|
VO-DINH, TUAN
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
EORTC HEADQUARTERS
|
5U10CA011488-45
|
$250,025
|
LACOMBE, DENIS
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genomic studies for understanding etiology of esophageal adenocarcinoma
|
1R21CA197502-01
|
$246,080
|
DAI, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
2P30CA015704-40
|
$9,785,343
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S1
|
$28,376
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S2
|
$84,156
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S3
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S4
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-02
|
$6,686,248
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Esophageal Cancer from Cells to Population: A Multiscale Approach
|
5U01CA182940-03
|
$665,400
|
LUEBECK, GEORG
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
|
3R01CA179949-02S1
|
$199,830
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-12
|
$2,462,800
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
|
5R01CA179949-03
|
$375,018
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL
|
5K05CA124911-09
|
$151,209
|
VAUGHAN, THOMAS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-02
|
$280,000
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Esophageal cancer in West Kenya
|
1R21CA191965-01
|
$85,466
|
MCCORMACK, VALERIE
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|